Literature DB >> 19238028

Treatment of irritable bowel syndrome-diarrhea with pancrealipase or colesevelam and association with steatorrhea.

Mary E Money, Alan F Hofmann, Lee R Hagey, Jaroslaw Walkowiak, Nicholas J Talley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19238028     DOI： 10.1097/MPA.0b013e31817c1b36

Source DB:  PubMed          Journal:  Pancreas        ISSN： 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  6 in total

Review 1.  New treatments for IBS.

Authors:  Magnus Halland; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-13       Impact factor: 46.802

Review 2.  Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes.

Authors:  Paul M Hobbs; William G Johnson; David Y Graham
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

3.  Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels.

Authors:  Stephen J Keely; Andreacarola Urso; Alexandr V Ilyaskin; Christoph Korbmacher; Nigel W Bunnett; Daniel P Poole; Simona E Carbone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-11-10       Impact factor: 4.052

Review 4.  Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.

Authors:  Tony Trang; Johanna Chan; David Y Graham
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

5.  Irritable bowel syndrome: the role of food in pathogenesis and management.

Authors:  Paula A Hayes; Marianne H Fraher; Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-03

6.  Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea.

Authors:  Mary E Money; Jaroslaw Walkowiak; Chris Virgilio; Nicholas J Talley
Journal:  Frontline Gastroenterol       Date:  2010-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.